David A. Finkelstein
Fondateur chez Path Systems, Inc.
Profil
David A.
Finkelstein has been Chief Strategy Officer of Interleukin Genetics, Inc. since August 17, 2006.
Prior to joining Interleukin, he had been Chief Operating Officer and Founder of the Alan James Group LLC since 2002.
Prior to founding Alan James Group, Mr. Finkelstein was the Founder of Fusive.com Corp.
He received a BSME from the University of Vermont and an MBA from York University, Toronto, Canada.
Postes actifs de David A. Finkelstein
| Sociétés | Poste | Début |
|---|---|---|
| Path Systems, Inc. | Fondateur | 03/06/2010 |
| Reference Media Corp. | Fondateur | 03/06/2010 |
Anciens postes connus de David A. Finkelstein
| Sociétés | Poste | Fin |
|---|---|---|
| INTERLEUKIN GENETICS, INC | Corporate Officer/Principal | 02/07/2007 |
Formation de David A. Finkelstein
| University of Vermont | Undergraduate Degree |
| York University | Masters Business Admin |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Interleukin Genetics, Inc.
 Interleukin Genetics, Inc. Pharmaceuticals: MajorHealth Technology Interleukin Genetics, Inc. engages in the marketing and development of proprietary genetic tests for chronic inflammatory diseases and health-related conditions focuses on metabolism and inflammation. The company was founded in 1986 and is headquartered in Waltham, MA. | Health Technology |
| Path Systems, Inc. | |
| Reference Media Corp. |
